JD Health International Inc.
JDHIFOTCHealthcare● Active
$5.85
+$0.00(+0.00%)
Market Cap$18.7B
P/E Ratio—
52W High$8.75
52W Low$3.23
JD Health International Inc. (JDHIF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
JDHIF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 5, 2026EPS Actual
$0.13
Revenue
$5.45B
Est. $5.34B · +2.1%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 5, 2026
After Market Close
▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
JDHIF reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | $0.17 | — | — | — | $6.10B | — |
| — Q1 FY2026 | Mar 5, 2026 | — | $0.13 | — | $5.45B | $5.34B | +2.1% |
| ▲ Q1 FY2025 | Mar 6, 2025 | $0.09 | $0.09 | +6.7% | $4.08B | $4.05B | +0.7% |
| ▼ Q3 FY2024 | Aug 15, 2024 | $0.09 | $0.09 | -2.2% | $3.90B | $4.04B | -3.4% |
| ▼ Q2 FY2024 | Jun 21, 2024 | $0.06 | $0.03 | -58.5% | $3.73B | $3.64B | +2.3% |
| ▲ Q2 FY2023 | Jun 30, 2023 | $0.05 | $0.07 | +28.4% | $3.74B | $3.83B | -2.3% |
| ▼ Q4 FY2022 | Dec 31, 2022 | $0.05 | $0.01 | -84.0% | $3.87B | $3.55B | +8.9% |
| ▼ Q2 FY2022 | Jun 30, 2022 | $0.03 | $0.01 | -66.9% | $3.02B | $2.89B | +4.4% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
$0.17
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 5, 2026
EPS Actual
$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
$5.45B
Q1 FY2025
Mar 6, 2025Beat
EPS Actual
$0.09
EPS Est.
$0.09
EPS Surpr.
+6.7%
Revenue
$4.08B
Q3 FY2024
Aug 15, 2024Miss
EPS Actual
$0.09
EPS Est.
$0.09
EPS Surpr.
-2.2%
Revenue
$3.90B
Q2 FY2024
Jun 21, 2024Miss
EPS Actual
$0.03
EPS Est.
$0.06
EPS Surpr.
-58.5%
Revenue
$3.73B
Q2 FY2023
Jun 30, 2023Beat
EPS Actual
$0.07
EPS Est.
$0.05
EPS Surpr.
+28.4%
Revenue
$3.74B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
$0.01
EPS Est.
$0.05
EPS Surpr.
-84.0%
Revenue
$3.87B
Q2 FY2022
Jun 30, 2022Miss
EPS Actual
$0.01
EPS Est.
$0.03
EPS Surpr.
-66.9%
Revenue
$3.02B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $19.3B | $19.8B | $20.1B | 3 |
| Q3 FY2025 | $16.5B | $16.6B | $16.6B | 2 |
| Q2 FY2025 | $17.6B | $17.8B | $18.1B | 2 |
| Q4 FY2024 | $16.4B | $16.4B | $16.4B | 1 |
| Q3 FY2024 | $13.3B | $13.3B | $13.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 5, 2026 | — | $6.49 | $6.15 | -5.24% |
| ▲ Q1 FY2025 | Mar 6, 2025 | +6.7% | $3.13 | $3.13 | +0.00% |
| ▼ Q3 FY2024 | Aug 15, 2024 | -2.2% | $3.13 | $3.13 | +0.00% |
| ▼ Q2 FY2024 | Jun 21, 2024 | -58.5% | $3.65 | $3.13 | -14.25% |
| ▲ Q2 FY2023 | Jun 30, 2023 | +28.4% | $6.21 | $6.21 | +0.00% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -84.0% | $9.59 | $9.59 | +0.00% |
| ▼ Q2 FY2022 | Jun 30, 2022 | -66.9% | $6.19 | $6.19 | +0.00% |
| ▼ Q4 FY2021 | Dec 31, 2021 | -213.6% | $7.70 | $7.70 | +0.00% |
Q1 FY2026-5.24%
Report Date
Mar 5, 2026
EPS Beat/Miss
—
Price Before
$6.49
Price After
$6.15
Q1 FY2025+0.00%
Report Date
Mar 6, 2025
EPS Beat/Miss
+6.7%
Price Before
$3.13
Price After
$3.13
Q3 FY2024+0.00%
Report Date
Aug 15, 2024
EPS Beat/Miss
-2.2%
Price Before
$3.13
Price After
$3.13
Q2 FY2024-14.25%
Report Date
Jun 21, 2024
EPS Beat/Miss
-58.5%
Price Before
$3.65
Price After
$3.13
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
+28.4%
Price Before
$6.21
Price After
$6.21
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-84.0%
Price Before
$9.59
Price After
$9.59
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
-66.9%
Price Before
$6.19
Price After
$6.19
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
-213.6%
Price Before
$7.70
Price After
$7.70
Avg Beat Reaction+0.00%
Avg Miss Reaction-2.85%
Beat Rate2 / 8 quarters
Largest Move-14.25% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: JDHIF ends December
JD Health International Inc. (JDHIF) most recently reported earnings on March 5, 2026 for Q1 FY2026, posting EPS of $0.13 (in line with the analyst consensus of —).
Each quarter, investors track JDHIF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. JDHIF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
JDHIF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
JDHIF earnings · 4 questionsJD Health International Inc.'s next earnings report is expected around TBD. JDHIF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; JDHIF historically reports after market close (AMC).
JDHIF earnings datewhen is JDHIF earningsJDHIF next earnings datewhen does JDHIF report earningsJDHIF earnings calendar
▸ Source: FMP · JD Health International Inc. SEC filings · US GAAP · JD Health International Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026